Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | 0.0012 | 0.0031 | 0.0088 |
Mycobacterium ulcerans | thioesterase | 0.0166 | 0.2668 | 0.2668 |
Mycobacterium tuberculosis | Probable threonyl-tRNA synthetase ThrS (threonine-tRNA synthetase)(ThrRS) (threonine-tRNA ligase) | 0.0047 | 0.0639 | 0.0639 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0012 | 0.0031 | 0.0031 |
Wolbachia endosymbiont of Brugia malayi | isoleucyl-tRNA synthetase | 0.006 | 0.0863 | 0.614 |
Mycobacterium ulcerans | glycyl-tRNA synthetase | 0.0011 | 0.0023 | 0.0023 |
Echinococcus multilocularis | isoleucyl tRNA synthetase, mitochondrial | 0.0048 | 0.0643 | 0.7376 |
Schistosoma mansoni | isoleucine--tRNA ligase | 0.006 | 0.0863 | 1 |
Mycobacterium tuberculosis | Peptide synthetase MbtE (peptide synthase) | 0.0017 | 0.012 | 0.012 |
Brugia malayi | AMP-binding enzyme family protein | 0.0014 | 0.0075 | 0.0619 |
Leishmania major | leucyl-tRNA synthetase, putative | 0.0021 | 0.0195 | 0.2041 |
Plasmodium falciparum | valine--tRNA ligase, putative | 0.0021 | 0.0195 | 0.0988 |
Trypanosoma cruzi | threonyl-tRNA synthetase, putative | 0.0054 | 0.0748 | 0.8631 |
Treponema pallidum | valyl-tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Trichomonas vaginalis | isoleucyl tRNA synthetase, putative | 0.006 | 0.0863 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0012 | 0.0031 | 0.0088 |
Mycobacterium ulcerans | phenyloxazoline synthase MbtB | 0.0183 | 0.296 | 0.296 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0048 | 0.0295 |
Wolbachia endosymbiont of Brugia malayi | threonyl-tRNA synthetase | 0.0047 | 0.0639 | 0.4501 |
Echinococcus multilocularis | leucyl tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Echinococcus granulosus | leucyl tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Echinococcus granulosus | isoleucyl tRNA synthetase, cytoplasmic | 0.006 | 0.0863 | 1 |
Chlamydia trachomatis | threonine--tRNA ligase | 0.0054 | 0.0748 | 0.8631 |
Mycobacterium ulcerans | leucyl-tRNA synthetase | 0.0013 | 0.0048 | 0.0048 |
Wolbachia endosymbiont of Brugia malayi | valyl-tRNA synthetase | 0.0021 | 0.0195 | 0.1253 |
Loa Loa (eye worm) | threonyl-tRNA synthetase | 0.0054 | 0.0748 | 0.8631 |
Brugia malayi | valyl-tRNA synthetase family protein | 0.0021 | 0.0195 | 0.2041 |
Plasmodium falciparum | isoleucine--tRNA ligase, putative | 0.006 | 0.0863 | 0.4841 |
Entamoeba histolytica | valyl tRNA synthetase, putative | 0.0021 | 0.0195 | 0.2041 |
Plasmodium vivax | hypothetical protein, conserved | 0.0021 | 0.0195 | 0.2041 |
Schistosoma mansoni | threonyl-tRNA synthetase | 0.0043 | 0.0561 | 0.6401 |
Onchocerca volvulus | 0.0017 | 0.012 | 0.1202 | |
Trichomonas vaginalis | leucyl-tRNA synthetase, putative | 0.0013 | 0.0048 | 0.0295 |
Mycobacterium leprae | Probable threonyl-tRNA synthetase ThrS (threonine-tRNA synthetase) (ThrRS) (Threonine-tRNA ligase) | 0.0047 | 0.0639 | 0.0639 |
Plasmodium falciparum | isoleucine--tRNA ligase, putative | 0.0113 | 0.1759 | 1 |
Trypanosoma brucei | valyl-tRNA synthetase, putative | 0.0021 | 0.0195 | 0.2041 |
Mycobacterium ulcerans | pantoate--beta-alanine ligase | 0.0594 | 1 | 1 |
Trichomonas vaginalis | valyl-tRNA synthetase, putative | 0.0013 | 0.0048 | 0.0295 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0014 | 0.0068 | 0.0068 |
Treponema pallidum | leucyl-tRNA synthetase | 0.0013 | 0.0048 | 0.0295 |
Trichomonas vaginalis | leucyl-tRNA synthetase, putative | 0.0021 | 0.0195 | 0.2041 |
Mycobacterium tuberculosis | Pantoate--beta-alanine ligase PanC (pantothenate synthetase) (pantoate activating enzyme) | 0.0594 | 1 | 1 |
Trichomonas vaginalis | threonyl-tRNA synthetase, putative | 0.0047 | 0.0639 | 0.7331 |
Echinococcus granulosus | Threonyl tRNA synthetase C | 0.0054 | 0.0748 | 0.8631 |
Mycobacterium tuberculosis | Isoleucyl-tRNA synthetase IleS | 0.0039 | 0.0496 | 0.0496 |
Treponema pallidum | threonyl-tRNA synthetase | 0.0047 | 0.0639 | 0.7331 |
Trypanosoma cruzi | valyl-tRNA synthetase, putative | 0.0013 | 0.0048 | 0.0295 |
Echinococcus multilocularis | leucyl tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Trichomonas vaginalis | isoleucyl, leucyl, tyrosyl, valyl and methionyl-tRNA synthetases, putative | 0.0013 | 0.0048 | 0.0295 |
Entamoeba histolytica | isoleucyl-tRNA synthetase, putative | 0.006 | 0.0863 | 1 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0534 | 0.898 | 0.898 |
Leishmania major | valyl-tRNA synthetase, putative | 0.0021 | 0.0195 | 0.2041 |
Plasmodium falciparum | leucine--tRNA ligase, putative | 0.0021 | 0.0195 | 0.0988 |
Plasmodium vivax | isoleucine--tRNA ligase, putative | 0.006 | 0.0863 | 1 |
Mycobacterium ulcerans | threonyl-tRNA synthetase | 0.0047 | 0.0639 | 0.0639 |
Toxoplasma gondii | leucyl-tRNA synthetase (LeuRS2) | 0.0021 | 0.0195 | 0.0172 |
Giardia lamblia | Threonyl-tRNA synthetase | 0.0047 | 0.0639 | 0.7331 |
Echinococcus multilocularis | methionyl tRNA synthetase, cytoplasmic | 0.0013 | 0.0048 | 0.0295 |
Schistosoma mansoni | leucyl-tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Plasmodium falciparum | threonine--tRNA ligase | 0.0047 | 0.0639 | 0.3549 |
Mycobacterium tuberculosis | Probable valyl-tRNA synthase protein ValS (valyl-tRNA synthetase) (valine--tRNA ligase) (valine translase) | 0.0021 | 0.0195 | 0.0195 |
Toxoplasma gondii | isoleucyl-tRNA synthetase, putative | 0.0021 | 0.0195 | 0.0172 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0048 | 0.0295 |
Mycobacterium ulcerans | peptide synthetase Nrp (peptide synthase) | 0.0017 | 0.012 | 0.012 |
Mycobacterium leprae | isoleucyl-tRNA synthetase IleS | 0.006 | 0.0863 | 0.0863 |
Trypanosoma brucei | leucyl-tRNA synthetase, putative | 0.0021 | 0.0195 | 0.2041 |
Entamoeba histolytica | leucyl-tRNA synthetase, putative | 0.0021 | 0.0195 | 0.2041 |
Trypanosoma cruzi | threonyl-tRNA synthetase, putative | 0.0054 | 0.0748 | 0.8631 |
Mycobacterium ulcerans | prolyl-tRNA synthetase | 0.0011 | 0.0023 | 0.0023 |
Trypanosoma brucei | isoleucyl-tRNA synthetase, putative | 0.006 | 0.0863 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0017 | 0.012 | 0.1146 |
Chlamydia trachomatis | isoleucine--tRNA ligase | 0.006 | 0.0863 | 1 |
Chlamydia trachomatis | leucine--tRNA ligase | 0.0013 | 0.0048 | 0.0295 |
Leishmania major | threonyl-tRNA synthetase, putative | 0.0054 | 0.0748 | 0.8631 |
Onchocerca volvulus | 0.0048 | 0.0643 | 1 | |
Entamoeba histolytica | valyl-tRNA synthetase, putative | 0.0021 | 0.0195 | 0.2041 |
Mycobacterium tuberculosis | Probable peptide synthetase Nrp (peptide synthase) | 0.0017 | 0.012 | 0.012 |
Trypanosoma brucei | threonyl-tRNA synthetase, putative | 0.0054 | 0.0748 | 0.8631 |
Toxoplasma gondii | valyl-tRNA synthetase | 0.0021 | 0.0195 | 0.0172 |
Toxoplasma gondii | leucyl-tRNA synthetase | 0.0021 | 0.0195 | 0.0172 |
Onchocerca volvulus | 0.0017 | 0.012 | 0.1202 | |
Brugia malayi | isoleucyl-tRNA synthetase family protein | 0.006 | 0.0863 | 1 |
Wolbachia endosymbiont of Brugia malayi | leucyl-tRNA synthetase | 0.0021 | 0.0195 | 0.1253 |
Mycobacterium leprae | Probable formamidopyrimidine-DNA glycosylase Fpg (FAPY-DNA GLYCOSYLASE) | 0.0091 | 0.1391 | 0.1391 |
Echinococcus granulosus | valyl tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Mycobacterium ulcerans | non-ribosomal peptide synthetase MbtF | 0.0017 | 0.012 | 0.012 |
Onchocerca volvulus | 0.0021 | 0.0195 | 0.2466 | |
Chlamydia trachomatis | methionine--tRNA ligase | 0.0013 | 0.0048 | 0.0295 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0014 | 0.0068 | 0.0068 |
Mycobacterium ulcerans | formamidopyrimidine-DNA glycosylase | 0.0091 | 0.1391 | 0.1391 |
Mycobacterium tuberculosis | Possible DNA glycosylase | 0.0091 | 0.1391 | 0.1391 |
Loa Loa (eye worm) | isoleucyl-tRNA synthetase | 0.006 | 0.0863 | 1 |
Brugia malayi | isoleucyl-tRNA synthetase | 0.006 | 0.0863 | 1 |
Schistosoma mansoni | valine-tRNA ligase | 0.0021 | 0.0195 | 0.2041 |
Trypanosoma cruzi | isoleucyl-tRNA synthetase, putative | 0.006 | 0.0863 | 1 |
Echinococcus multilocularis | isoleucyl tRNA synthetase, cytoplasmic | 0.006 | 0.0863 | 1 |
Giardia lamblia | Valine-tRNA ligase | 0.0021 | 0.0195 | 0.2041 |
Echinococcus multilocularis | Threonyl tRNA synthetase, C | 0.0054 | 0.0748 | 0.8631 |
Leishmania major | isoleucyl-tRNA synthetase, putative | 0.006 | 0.0863 | 1 |
Echinococcus granulosus | isoleucyl trna synthetase mitochondrial | 0.0048 | 0.0643 | 0.7376 |
Mycobacterium ulcerans | isoleucyl-tRNA synthetase | 0.006 | 0.0863 | 0.0863 |
Mycobacterium leprae | Probable prolyl tRNA synthetase ProS | 0.0011 | 0.0023 | 0.0023 |
Giardia lamblia | Isoleucyl-tRNA synthetase | 0.006 | 0.0863 | 1 |
Schistosoma mansoni | methyltransferase-related | 0.0012 | 0.0031 | 0.0088 |
Echinococcus granulosus | leucyl tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Toxoplasma gondii | isoleucyl-tRNA synthetase family protein | 0.006 | 0.0863 | 0.0842 |
Entamoeba histolytica | threonyl-tRNA synthetase, putative | 0.0047 | 0.0639 | 0.7331 |
Giardia lamblia | Methyltransferase like 2 | 0.0012 | 0.0031 | 0.0088 |
Toxoplasma gondii | tRNA synthetase, putative | 0.0021 | 0.0195 | 0.0172 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0017 | 0.012 | 0.1146 |
Plasmodium falciparum | valine--tRNA ligase, putative | 0.0021 | 0.0195 | 0.0988 |
Mycobacterium tuberculosis | Peptide synthetase MbtF (peptide synthase) | 0.0017 | 0.012 | 0.012 |
Wolbachia endosymbiont of Brugia malayi | formamidopyrimidine-DNA glycosylase | 0.0091 | 0.1391 | 1 |
Treponema pallidum | isoleucyl-tRNA synthetase | 0.006 | 0.0863 | 1 |
Chlamydia trachomatis | valine--tRNA ligase | 0.0021 | 0.0195 | 0.2041 |
Mycobacterium ulcerans | non-ribosomal peptide synthetase MbtE | 0.0017 | 0.012 | 0.012 |
Plasmodium vivax | threonine--tRNA ligase, putative | 0.0047 | 0.0639 | 0.7331 |
Trypanosoma cruzi | valyl-tRNA synthetase, putative | 0.0021 | 0.0195 | 0.2041 |
Trichomonas vaginalis | leucyl-tRNA synthetase, putative | 0.0021 | 0.0195 | 0.2041 |
Schistosoma mansoni | valine-tRNA ligase | 0.0021 | 0.0195 | 0.2041 |
Echinococcus granulosus | methionyl tRNA synthetase cytoplasmic | 0.0013 | 0.0048 | 0.0295 |
Toxoplasma gondii | pantoate-beta-alanine ligase | 0.0594 | 1 | 1 |
Plasmodium vivax | valine--tRNA ligase, putative | 0.0021 | 0.0195 | 0.2041 |
Trypanosoma cruzi | leucyl-tRNA synthetase, putative | 0.0021 | 0.0195 | 0.2041 |
Mycobacterium tuberculosis | Probable formamidopyrimidine-DNA glycosylase Fpg (FAPY-DNA glycosylase) | 0.0091 | 0.1391 | 0.1391 |
Mycobacterium tuberculosis | Conserved protein | 0.0012 | 0.0031 | 0.0031 |
Echinococcus multilocularis | valyl tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0075 | 0.0619 |
Schistosoma mansoni | methionine-tRNA synthetase | 0.0013 | 0.0048 | 0.0295 |
Brugia malayi | leucyl-tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0863 | 1 |
Echinococcus granulosus | valyl tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Brugia malayi | Valyl-tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Brugia malayi | Methyltransferase-like protein 4 | 0.0012 | 0.0031 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0195 | 0.2041 |
Echinococcus multilocularis | valyl tRNA synthetase | 0.0021 | 0.0195 | 0.2041 |
Mycobacterium ulcerans | valyl-tRNA synthetase | 0.0021 | 0.0195 | 0.0195 |
Toxoplasma gondii | threonyl-tRNA synthetase family protein | 0.0047 | 0.0639 | 0.0617 |
Mycobacterium ulcerans | formamidopyrimidine-DNA glycosylase | 0.0091 | 0.1391 | 0.1391 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0643 | 0.7376 |
Mycobacterium leprae | PROBABLE VALYL-tRNA SYNTHASE PROTEIN VALS (VALYL-tRNA SYNTHETASE) (VALINE--tRNA LIGASE) (VALINE TRANSLASE) ELONGS TO CLASS-I AMI | 0.0021 | 0.0195 | 0.0195 |
Brugia malayi | threonyl-tRNA synthetase, cytoplasmic | 0.0054 | 0.0748 | 0.8631 |
Schistosoma mansoni | isoleucine--tRNA ligase | 0.006 | 0.0863 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.